Everything you wanted to know about SOX17 in pulmonary arterial hypertension #PAH in our new article in Eur Respir Rev
Absolutely loved working on this one!
@pulmotension@InsermU999@HTaPFrance@SPLF_SocPneumo
https://t.co/JstPxDFqcC
Proud to share our new publication in Respiratory Medicine and Research 'PAH-approved drugs in PH associated with COPD: a systematic literature review.'
Grateful to my co-authors !
@SPLF_SocPneumo@pulmotension@SPLF_SocPneumo@InsermU999
https://t.co/C1pyvH8y0u
@RERB Les retards sont attendus étant donné le nombre de passagers et les multiples incidents possibles. Ce qui est anormal est l'absence de communication. Le trafic a été noté normal pendant tout l'incident, vous ne l'avez pas tweeter hormis en réponse et aucune annonce n'a été faite.
Coming out of Twitter retirement to share a very important and impactful paper published today in @NEJM : The #ZENITH trial of #sotatercept for high-risk patients with #pah.
Primary endpoint morbidity/mortality HR, 0.24; 95% CI, 0.13 to 0.43
https://t.co/u2F7B5eoo3
The #ADAPTtrial results are interesting…
Compared to SOC, Procalcitonin guided antibiotic therapy resulted in:
- FEWER antibiotic days: 10.7 vs 9.8 (p=0.01) BUT
- HIGHER 28 day mortality: 19.4% vs 20.9% (p=0.02) though less than the pre-specified non-inferiority margin
A🧵
1/
Severity of Airflow Obstruction Based on FEV1/FVC vs FEV1 Percent Predicted in the General US Population
🔓 Open Access
This study shows that both a low FEV1/FVC and a low FEV1 percent predicted are important predictors of symptoms and mortality
🔗 https://t.co/ktENhLgACa
👮♂️« On l’a défoncé, mais le mec il sentait rien c’était ouf ».
Quatre ans après l’agression de Michel Zecler, @davidperrotin poursuit ses révélations en publiant des messages qui pulvérisent la version des policiers.👇
https://t.co/cQxKwjVAhR
A #JournalCHEST Special Feature summarizes disease presentations and provides a practical approach to diagnosis of organizing #pneumonia. Read and share this research ahead of #WorldPneumoniaDay (November 12): https://t.co/fTAfpWgoIj
#MedEd#MedTwitter
Through
- rigorous QI
- feedback
- sharing of videolaryngoscopy footage
- and a massive investment of effort in emergency doctor and resus nurse training
We have achieved incremental improvements in first pass success rates
2/14
⚠️ We call for an urgent revision of current societal guidelines recommending a 1-week pre-operative discontinuation interval of semaglutide in patients undergoing elective procedures under anaesthesia ⚠️
Peri-op semaglutide use up to 10 days before elective surgical procedures was associated with an increased risk of increased residual gastric content despite appropriate fasting.
https://t.co/rCyZyGuYOM
Free scientific illustrations for biologists! 😍
@NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations!
all freely available in the public domain.
Retweet and spread the message!
https://t.co/p1bD1kxO7H